SEC Tracker
Get the app

Hepion Pharmaceuticals HEPA

Hepion Pharmaceuticals (HEPA) reports new shareholder

Ownership stake disclosure

Form
Schedule 13D
Filed
Importance
Notable
  1. Gravitas Collective Corp. received 25,000,000 shares of HEPA common stock
  2. The shares were exchanged for membership interests in Gravitas Life Sciences, Inc.
  3. The Reporting Person is a New Jersey corporation
  4. The transaction was for investment purposes

Written from the Schedule 13D on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Hepion Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. China Foods Holdings CFOO public float $864K, Jun 30, 2025
  2. Mosaic ImmunoEngineering CPMV public float $856K, Jun 30, 2025
  3. Twinlab Consolidated Holdings TLCC public float $1M, Jun 30, 2025
  4. Regen BioPharma RGBP public float $1M, Mar 31, 2025, over 18 months old
  5. Nutra Pharma NPHC public float $703K, Jun 30, 2025